SOLACI at ACC / AHA / SCAI recommendation guides

The Latin American Society of Interventional Cardiology (SOLACI) has the honor to inform all members that after three years of work; SOLACI has been incorporated into the way of endorsement, to the ACC/AHA/SCAI’s guides.

We are positive that this action will be perceived by all our members as a step forward in the relationship and positioning of SOLACI between the most important societies of cardiology and interventionism in the world.

The Board of Directors and the Advisory Council acknowledge the efforts made by former SOLACI president Dr. Oscar Mendiz, and send a renewed stimulus of participation to all our members, so this organization can continue to grow and develop to fulfill its mission to promote and improve the practice of Cardiovascular Interventionism in Latin America.

Jamil Abdalla Saad
SOLACI President (2013-2015)
experts-consensus-document-resumen-ejecutivo

// Full document

// Live cases

More articles by this author

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

Uruguay Sessions 2025 | Young Interventional Cardiologists Contest

Call for Case Submission LI SOLACI Regional Sessions – 16° Southern Cone  It is with great pleasure that we hereby invite all young Latin American cardiologists...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...